Copinox Lamb 2 g Capsule, Hard

देश: यूनाइटेड किंगडम

भाषा: अंग्रेज़ी

स्रोत: VMD (Veterinary Medicines Directorate)

सक्रिय संघटक:

Copper Oxide

थमां उपलब्ध:

Animax Ltd

ए.टी.सी कोड:

QA12CX

INN (इंटरनेशनल नाम):

Copper Oxide

फार्मास्यूटिकल फॉर्म:

Capsule, hard

प्रिस्क्रिप्शन प्रकार:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

चिकित्सीय समूह:

Sheep

चिकित्सीय क्षेत्र:

Mineral

प्राधिकरण का दर्जा:

Authorized

प्राधिकरण की तारीख:

1999-12-23

उत्पाद विशेषताएं

Revised: July 2022
AN: 00089/2022
Page 1 of 5
SUMMARY OF PRODUCTS CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Copinox Lamb 2 g Capsule, Hard
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance
Each 2g capsule provides copper oxide equivalent to 1.74g elemental
copper
Excipients
E171 – Titanium dioxide 1.9 % w/w
For full list of excipients see Section 6.1
3.
PHARMACEUTICAL FORM
Capsule, hard.
White capsule size Oel
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep, (lambs)
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of hypocuprosis in sheep
4.3
CONTRA-INDICATIONS
Do not use unless copper deficiency is known to exist or known to be a
risk.
Do not administer to pre-ruminant lambs or lambs under 10kg bodyweight
or
less than 5 weeks old.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Caution is advised and veterinary advice should be sought before
treating
housed sheep and breeds such as North Ronaldsays, Texels and Lleyns
known to be sensitive to copper poisoning.
This product is not effective in alleviating signs of swayback in
lambs which
already show signs of the disease.
Revised: July 2022
AN: 00089/2022
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Animals should only be dosed if copper deficiency is known to
exist or known to be a risk.
No other form of copper supplementation should be given
immediately prior to or 6 months after administration of the
capsules.
Do not exceed the recommended dose.
Care must be taken when dosing animals to avoid causing injury
to the mouth and pharynx.
ii.
Special precautions for the person administering the veterinary
medicinal product to animals
None.
iii.
Other precautions
None.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Not to be expected provided the recommended dosage regimes are
followed.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
No adverse effects known
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Copper reacts with many eleme